Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27:283-289
Published online before print October 19, 2006, doi: 10.1161/01.ATV.0000250606.70669.14
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
27/2/283    most recent
01.ATV.0000250606.70669.14v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shiba, Y.
Right arrow Articles by Ikeda, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shiba, Y.
Right arrow Articles by Ikeda, U.
Related Collections
Right arrowRelated Article
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27:283.)
© 2007 American Heart Association, Inc.


Vascular Biology

M-CSF Accelerates Neointimal Formation in the Early Phase After Vascular Injury in Mice

The Critical Role of the SDF-1–CXCR4 System

Yuji Shiba; Masafumi Takahashi; Toru Yoshioka; Noriyuki Yajima; Hajime Morimoto; Atsushi Izawa; Hirohiko Ise; Kiyohiko Hatake; Kazuo Motoyoshi; Uichi Ikeda

From the Division of Cardiovascular Sciences, Department of Organ Regeneration (Y.S., M.T., T.Y., N.Y., H.M., A.I., H.I., U.I.), Shinshu University Graduate School of Medicine, Matsumoto; the Cancer Chemotherapy Center (K.H.), Japanese Foundation for Cancer Research, Tokyo; and the Third Department of Internal Medicine (K.M.), National Defense Medical College, Saitama, Japan.

Correspondence to Masafumi Takahashi, MD, PhD, Division of Cardiovascular Sciences, Department of Organ Regeneration, Shinshu University Graduate School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan. E-mail masafumi{at}sch.md.shinshu-u.ac.jp

Objective— Since the macrophage colony-stimulating factor (M-CSF) has been shown to stimulate differentiation and proliferation of monocyte/macrophage lineage and to be involved in the process of neointimal formation after vascular injury, we tested the effects of M-CSF on the recruitment of bone marrow-derived progenitor cells in neointimal formation after vascular injury in mice.

Methods and Results— Wire-mediated vascular injury was produced in the femoral artery of C57BL/6 mice. Recombinant human M-CSF [500 µg/(kg·day)] or saline (control) was administered for 10 consecutive days, starting 4 days before the injury. Treatment with M-CSF accelerated neointimal formation in the early phase after injury, and this neointimal lesion mainly consisted of bone marrow-derived cells. M-CSF treatment had no effect on the mobilization of endothelial progenitor cells (EPCs: CD34+/Flk-1+) and reendothelialization after injury. The stromal cell-derived factor-1 (SDF-1) was markedly expressed in the neointima and media after injury, whereas CXCR4+ cells were observed in the neointima. Further, a novel CXCR4 antagonist, AMD3100, significantly attenuated the M-CSF-induced neointimal formation.

Conclusions— These findings suggest that M-CSF accelerated neointimal formation after vascular injury via the SDF-1–CXCR4 system, and the inhibition of this system has therapeutic potential for the treatment of cardiovascular diseases.

We tested the effects of M-CSF on the recruitment of bone marrow-derived progenitor cells in neointimal formation after vascular injury in mice. The findings obtained from this study demonstrated that M-CSF accelerated neointimal formation in the early phase after vascular injury via the SDF-1–CXCR4 system.


Key Words: angioplasty • cytokines • inflammation • restenosis • vascular biology


Related Article:

CXCR4, a Key Modulator of Vascular Progenitor Cells
Julie Sainz and Masataka Sata
Arterioscler. Thromb. Vasc. Biol. 2007 27: 263-265. [Extract] [Full Text] [PDF]